Denali Therapeutics
DNLI
#3955
Rank
โ‚ฌ2.00 B
Marketcap
13,79ย โ‚ฌ
Share price
1.23%
Change (1 day)
-1.08%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2023 (TTM): -1,05ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,92ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,29ย โ‚ฌ a decrease over its 2021 EPS that were of -2,10ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,05ย โ‚ฌ-53.89%
2022-2,29ย โ‚ฌ8.79%
2021-2,10ย โ‚ฌ-712.82%
20200,34ย โ‚ฌ-118.93%
2019-1,81ย โ‚ฌ402.44%
2018-0,36ย โ‚ฌ-88.89%
2017-3,25ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,64ย โ‚ฌ 77.14% Jersey
-6,32ย โ‚ฌ 584.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,81ย โ‚ฌ 96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-5,45ย โ‚ฌ 490.48%๐Ÿ‡ฌ๐Ÿ‡ง UK